BioInvent International AB (publ) Current Assets

As of the most recent data (June 2026), BOVNF shows a current assets of $380M. That compares with $880M in the prior-year period — down 56.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BOVNF's current assets is now $380M (was $880M) — a 56.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether BioInvent International AB (publ) is outperforming or lagging.

Tracking BOVNF's current assets over time shows whether BioInvent International AB (publ) is scaling, shrinking, or reshaping that part of the business. The current reading is $380M That compares with $880M in the prior-year period — down 56.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has BioInvent International AB (publ)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $380M) with ownership activity and broader fundamentals.

BioInvent International AB (publ)'s current assets is $380M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.